Martin D. Williams, Senior VP, Business Development, CBO at SYNTA PHARMACEUTICALS CORP (SNTA), bought 200 shares at $10.00 ($2K) on 2007-02-09, disclosed to the SEC on 2007-02-13.
Open-market purchase of $2k SNTA by Senior VP, Business Development, CBO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.